Particle Therapy Market Size & Share 2024 to 2032
Market Size by Type (Proton, Heavy Ion), by Product (Synchrotrons, Cyclotrons), by Services, by System (Multi-Room Systems, Single-Room Systems), by Cancer Type (Pediatric Cancer, Lung Cancer, Bladder, Breast Cancer) & Forecast.
Report ID: GMI6604
|
Published Date: August 2023
|
Report Format: PDF
Download Free PDF
Authors:
Monali Tayade, Jignesh Rawal
Particle Therapy Market Size
Particle Therapy Market size accounted for USD 837.09 million in 2023 and is estimated to grow at over 8.8% CAGR between 2024 and 2032. Particle therapy offers a multitude of advantages that serve as powerful growth drivers for its widespread adoption. One of the foremost drivers is its precision in targeting cancerous tissues. This precise targeting minimizes damage to surrounding healthy tissues, thereby reducing adverse effects, and enhancing patient quality of life during and after treatment.
Particle Therapy Market Key Takeaways
Market Size & Growth
Key Market Drivers
Challenges
The remarkable efficacy of particle therapy, especially for certain types of tumours that are resistant to conventional treatments is anticipated to aid market growth. Moreover, increasing number of particle therapy centers around the world are expected to drive market growth.
Particle therapy, also known as particle beam therapy, is an advanced form of cancer treatment that utilizes charged particles, such as protons or heavy ions, to deliver precise and targeted radiation therapy to cancerous tissues.
COVID-19 Impact
The emergence of the COVID-19 pandemic had a negative impact on particle therapy market. The pandemic led to widespread healthcare resource reallocation towards managing COVID-19 cases, diverting attention and resources away from non-COVID medical procedures, including particle therapy treatments. This shift resulted in delays or cancellations of scheduled treatments, causing setbacks in patient care and treatment plans, thereby hampering market growth. Additionally, travel restrictions and lockdown measures imposed to curb the virus's spread impeded patient access to particle therapy centers. Many patients were unable to travel to treatment facilities due to mobility restrictions or concerns about virus exposure, leading to a decline in patient numbers seeking particle therapy treatments. Such factors hindered market growth.
Particle Therapy Market Trends
Growing global burden of cancer is expected to boost the market growth. For instance, according to the American Cancer Society report, in 2022, there were an estimated 1.9 million new cancer cases diagnosed and 609,360 cancer deaths in the U.S. alone. As cancer cases continue to increase worldwide, the demand for innovative and effective treatment alternatives has become increasingly urgent. Particle therapy, known for its remarkable precision in targeting cancer cells while minimizing harm to healthy tissue, emerges as a compelling solution. Furthermore, particle therapy's ability to deliver highly focused radiation directly to the tumour site enhances the potential for successful outcomes and reduced collateral damage, thereby escalate the global market growth.
Particle Therapy Market Restraint
The particle therapy industry encounters a significant restraint in the form of infrastructural challenges within healthcare facilities. While particle therapy holds immense promise in revolutionizing cancer treatment, its successful implementation requires specialized infrastructure that can accommodate the unique demands of this advanced therapy. Furthermore, particle therapy centers need to house complex and sizable equipment, including particle accelerators and beam delivery systems, which demand substantial space and sophisticated shielding to ensure safety for both patients and medical staff. Moreover, the installation and maintenance of these intricate systems necessitate a high level of technical expertise and resources. Thus, the financial burden of establishing particle therapy facilities, coupled with the need for ongoing investments in maintenance and upgrades may hamper overall market growth.
Particle Therapy Market Analysis
By type, the particle therapy market is classified into proton therapy and heavy ion therapy. The proton therapy segment accounted for 72.7% of the market share in 2022 and is projected to witness significant growth over the analysis timeframe. The effectiveness of proton therapy is notably strong when dealing with paediatric cancers and intricate tumours situated near vital organs. Its ability to spare healthy tissues from unnecessary radiation exposure is crucial in these cases, making it a preferred option when considering the long-term well-being of patients, especially children. Furthermore, investments in research and development have led to the development of more compact and cost-effective proton therapy systems, making it feasible for a broader range of healthcare facilities to offer this advanced treatment option. Such aforementioned factors are expected to accelerate market statistics.
Based on product & services, the particle therapy market is segmented into product and services. The product segment accounted for 76.8% of the market share in 2022. The product segment is bifurcated into synchrotrons, cyclotrons, and synchrocyclotrons. Synchrotrons contribute to the advancement of research and innovation in particle therapy. Their versatile design allows for the exploration of various particle types and energies, enabling the development of tailored treatment plans for different cancer types. The versatility of synchrotrons also facilitates the conduct of cutting-edge experiments to refine treatment techniques and maximize therapeutic outcomes. Furthermore, the growing collaboration between research institutions and healthcare facilities in harnessing synchrotrons for particle therapy research contributes to their expansion.
Based on system, the particle therapy market is segmented into multi-room systems and single-room systems. The multi-room systems segment is projected to witness significant growth of 8.9% over the analysis timeframe. Multi-room systems notably enhance patient throughput and operational efficiency, allowing healthcare providers to concurrently treat multiple patients within a single facility. This efficient approach effectively reduces treatment waiting times and optimizes the utilization of valuable resources, thereby driving market growth. Furthermore, growing product approvals, launches, and partnerships among the companies are anticipated to escalate market demand.
Based on cancer type, the particle therapy market is segmented into pediatric cancer, lung cancer, bladder cancer, brain & spinal cord cancer, head & neck cancer, breast cancer, gastrointestinal cancer, and other cancer types. The lung cancer segment accounted for 15.5% of the market share in 2022 and is projected to witness significant CAGR over the analysis timeframe. Increasing prevalence of lung cancer across the globe is expected to accelerate segmental growth. For instance, according to the GLOBOCAN study carries out by the International Agency for Research on Cancer, in 2020, lung cancer was the major cause holding for the largest number of approximately 1.8 million cancer associated deaths followed by colorectal accounting for 9.4%, liver for 8.3%, stomach for 7.7%, and female breast cancer for 6.9%. Thus, the mounting burden of cancer will surge the investment in cancer research, thereby fostering market size.
North America particle therapy market accounted for 46% market share in 2022 and is anticipated to grow at considerable growth rate during the forecast timeframe. A significant driver propelling the growth of the market in North America is the region's robust research and development landscape coupled with substantial investments in healthcare innovation. This conducive environment fosters the continuous evolution of particle therapy technologies, leading to advanced treatment modalities and refined techniques. Additionally, the presence of prominent research institutions and collaborations between academia and healthcare facilities accelerates the validation and adoption of particle therapy. Furthermore, North America's emphasis on precision medicine and patient-centric care aligns well with the precision and tailored approaches that particle therapy offers, thereby boosting regional market statistics.
Particle Therapy Market Share
Major business players operating in the particle therapy market include
These industry players majorly adopt various strategies including collaborations, acquisitions, mergers, and partnerships to create a global footprint and sustain market competition.
Particle Therapy Industry News:
The particle therapy market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD from 2018 to 2032, for the following segments:
Click here to Buy Section of this Report
By Type
By Product & Services
By System
By Cancer Type
The above information is provided for the following regions and countries:
Research methodology, data sources & validation process
This report draws on a structured research process built around direct industry conversations, proprietary modelling, and rigorous cross-validation and not just desk research.
Our 6-step research process
1. Research design & analyst oversight
At GMI, our research methodology is built on a foundation of human expertise, rigorous validation, and complete transparency. Every insight, trend analysis, and forecast in our reports is developed by experienced analysts who understand the nuances of your market.
Our approach integrates extensive primary research through direct engagement with industry participants and experts, complemented by comprehensive secondary research from verified global sources. We apply quantified impact analysis to deliver dependable forecasts, while maintaining complete traceability from original data sources to final insights.
2. Primary research
Primary research forms the backbone of our methodology, contributing nearly 80% to overall insights. It involves direct engagement with industry participants to ensure accuracy and depth in analysis. Our structured interview program covers regional and global markets, with inputs from C-suite executives, directors, and subject matter experts. These interactions provide strategic, operational, and technical perspectives, enabling well-rounded insights and reliable market forecasts.
3. Data mining & market analysis
Data mining is a key part of our research process, contributing nearly 20% to the overall methodology. It involves analysing market structure, identifying industry trends, and assessing macroeconomic factors through revenue share analysis of major players. Relevant data is collected from both paid and unpaid sources to build a reliable database. This information is then integrated to support primary research and market sizing, with validation from key stakeholders such as distributors, manufacturers, and associations.
4. Market sizing
Our market sizing is built on a bottom-up approach, starting with company revenue data gathered directly through primary interviews, alongside production volume figures from manufacturers and installation or deployment statistics. These inputs are then pieced together across regional markets to arrive at a global estimate that stays grounded in actual industry activity.
5. Forecast model & key assumptions
Every forecast includes explicit documentation of:
✓ Key growth drivers and their assumed impact
✓ Restraining factors and mitigation scenarios
✓ Regulatory assumptions and policy change risk
✓ Technology adoption curve parameter
✓ Macroeconomic assumptions (GDP growth, inflation, currency)
✓ Competitive dynamics and market entry/exit expectations
6. Validation & quality assurance
The final stages involve human validation, where domain experts manually review filtered data to identify nuances and contextual errors that automated systems might miss. This expert review adds a critical layer of quality assurance, ensuring data aligns with research objectives and domain-specific standards.
Our triple-layer validation process ensures maximum data reliability:
✓ Statistical Validation
✓ Expert Validation
✓ Market Reality Check
Trust & credibility
Verified data sources
Trade publications
Security & defense sector journals and trade press
Industry databases
Proprietary and third-party market databases
Regulatory filings
Government procurement records and policy documents
Academic research
University studies and specialist institution reports
Company reports
Annual reports, investor presentations, and filings
Expert interviews
C-suite, procurement leads, and technical specialists
GMI archive
13,000+ published studies across 30+ industry verticals
Trade data
Import/export volumes, HS codes, and customs records
Parameters studied & evaluated
Every data point in this report is validated through primary interviews, true bottom-up modelling, and rigorous cross-checks. Read about our research process →